Search

Your search keyword '"Bergantim, Rui"' showing total 96 results

Search Constraints

Start Over You searched for: Author "Bergantim, Rui" Remove constraint Author: "Bergantim, Rui" Language english Remove constraint Language: english
96 results on '"Bergantim, Rui"'

Search Results

1. Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

2. Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

3. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

4. Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 Study

5. The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018

6. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings

7. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

8. An Assessment of the Effectiveness and Safety of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma Patients with Relapsed or Refractory Disease: A Systematic Review and Meta-Analysis.

9. Practical management of disease-related manifestations and drug toxicities in patients with multiple myeloma.

10. Multiple myeloma in elderly patients—a Portuguese multicentric real-life study

12. Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry.

13. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies

14. COVID-19 infection in adult patients with hematological malignancies:a European Hematology Association Survey (EPICOVIDEHA)

15. COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey

16. COVID-19 in adult acute myeloid leukemia patients: a long-term followup study from the European Hematology Association survey (EPICOVIDEHA)

18. Outcome of infection with omicron <scp>SARS‐ CoV</scp> ‐2 variant in patients with

19. Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients—A Proof of Concept.

21. Assessment of Multiple Myeloma-Related Burden on Caregivers - a Portuguese National Study

22. Aggressive Central Nervous System Relapse after Autologous Stem Cell Transplant in Multiple Myeloma: Case Reports and Literature Review

25. Impact of hematologic complete response in the treatment of sporadic late‐onset nemaline myopathy associated with monoclonal gammopathy.

26. Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma

28. Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy

30. Trend of depression and its association with sociodemographic and clinical factors among multiple myeloma hospitalizations: A Portuguese nationwide study from 2000 to 2015.

31. First Glimpse on Real-World Efficacy Outcomes for 2000 Patients with Systemic Light Chain Amyloidosis in Europe: A Retrospective Observational Multicenter Study By the European Myeloma Network

33. Severe neutropenia and thrombocytopenia in a young adult: a case-report.

40. miRNAs mediated drug resistance in hematological malignancies.

41. Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy.

42. The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance.

43. Multiple Myeloma: Available Therapies and Causes of Drug Resistance.

44. Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report

45. Relapsing COVID-19 in a Patient With Non-Hodgkin Lymphoma on Chemotherapy.

46. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.

47. Portuguese consensus on the prevention and treatment of nausea and vomiting induced by cancer treatments.

48. Diagnosis and referral of patients with AL amyloidosis in Portugal: results from a Delphi panel.

49. Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.

50. COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA).

Catalog

Books, media, physical & digital resources